MedPath

KIRSTY

KIRSTY

Approved
DIN Number

02520974

Drug Class

Human

Market Date

Oct 20, 2022

Company
HC

biocon sdn.bhd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02520974
AIG Number0144802001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AB05 INSULIN ASPART
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

INSULIN ASPARTActive
Strength: 100 UNIT / ML
Monograph: INSULIN ASPART

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.